ESC 365 - How patient advocacy in partnership with community pharmacy can identify people at risk of AF in community pharmacy setting

ESC Premium Access

How patient advocacy in partnership with community pharmacy can identify people at risk of AF in community pharmacy setting

Session: Poster session 5 - Demographics and screening

Topic: Atrial fibrillation (AF)

Speaker: Mrs T. Lobban (Oxford, GB)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Mrs Trudie Lobban

John Radcliffe Hospital, Oxford (United Kingdom of Great Britain & Northern Ireland)

6 presentations

1 follower

11 more presentations in this session

Screening for atrial fibrillation in the primary health care setting

Speaker: Doctor F. Ghazal (Stockholm, SE)

Benefits of active involvement of community pharmacists in know your pulse awareness campaign

Speaker: Doctor S. Antoniou (London, GB)

lipid profile and incidence of atrial fibrillation: results from the Kailuan Study

Speaker: Doctor Y. Xia (Dalian, CN)

Prevalence rates of atrial fibrillation tentatively increased during and after the Great East Japan earthquake.

Speaker: Doctor K. Tamaki (Morioka, JP)

Risk for adverse outcome events according to paroxysmal vs. non-paroxysmal atrial fibrillation

Speaker: Doctor S. Blum (Basel, CH)

Access the full session

Poster session 5 - Demographics and screening

Speakers: Mrs T. Lobban, Doctor F. Ghazal, Doctor S. Antoniou, Doctor Y. Xia, Doctor K. Tamaki...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources